首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 抗體和免疫 > 消化系統癌症之單株抗體:專利趨勢(2010年)
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

消化系統癌症之單株抗體:專利趨勢(2010年)

Monoclonal Antibodies against digestive system cancers:Patent Landscape 2010

出版商 France Innovation Scientifique et Transfert (FIST SA)
出版日期 2010年09月 商品編碼 133414
內容資訊 英文  
價格
US $ 4200 PDF by E-mail ( Single User License)


消化系統癌症之單株抗體:專利趨勢(2010年) 是由出版商France Innovation Scientifique et Transfert (FIST SA)在2010年09月所出版的。 這份英文市場調查報告書價格從美金4200起跳。

簡介

本報告為,關注為治療消化系統癌症所開發之單株抗體,並匯整市場趨勢及市場參與企業研發、智慧財產權組合、專利申請等,以下列摘要形式闡述。

概要

  • 技術概要
  • 市場概要:2009年
  • 產品線概要:2010年
  • 專利相關疑問

專利申請趨勢及地區

  • 專利申請(1988∼2008年)
  • 優先申請路徑及趨勢
  • 增加趨勢
  • 產業及機構申請趨勢
  • 申請人趨勢

專利申請分析

  • 主要申請人(1988∼2008年)
  • 10間申請人之組合
  • 產業及機構申請人之申請內容分析
  • 過去4年之申請人(2005∼2008年)
  • 申請人間之共同申請

投資家組合

  • 主要投資家清單
  • 主要研究團隊
  • 新興投資家

專利申請內容

  • 組合分析
    • 單株抗體種類
    • 單株抗體標靶
      • 生長因子受體
      • 細胞粘附分子
      • 其他標靶
    • 以單株抗體為標靶之消化系統癌症種類

ROCHE趨勢

  • 組織圖
  • 附屬公司申請專利流程及進展
  • 專利方針
  • 專利申請內容
  • 評語

引用及推廣分析

  • 引用最多之專利及專利應用
  • 引用分析中專利申請組合之定位
  • 最多推廣之專利
  • 覆蓋率分類

結論及附錄

  • 企業別單株抗體臨床實驗
  • 申請人、相關公司

目錄

Abstract

Description/Summary

In order to fight digestive system cancers, monoclonal antibody-based therapies have recently reinforced the range of already marketed treatments (mostly constituted of small molecules) and are generating important revenues. Four antibodies have already been approved but new ones are still needed. Many players are therefore trying to position themselves on this sector. This has resulted in an active patent policy that has nevertheless reached a plateau since 2005.

The present report analyses the patent environment and highlights the various monoclonal antibodies that have been developed to diagnose and treat oesophageal, gastric, bile duct, gastro-intestinal, colorectal, hepatic, pancreatic and anal cancers. The major trend is the development of human immunoconjugates against colorectal cancers by targeting growth factor receptors. Although this sector is surrounded by Roche and its subsidiaries, other players, and especially big pharma and biotech companies, continue to develop antibodies targeting new antigens and/or having new properties.

In this competitive sector driven by an important market and where 3000 patent families have been filed, this study « IP Overview - Monoclonal antibodies against digestive system cancers» provides you with a comprehensive panorama of the intellectual property landscape and helps you:

  • Position your company' s R&D and IP Portfolio
  • Identify key inventors and key players involved in the development of new monoclonal antibodies
  • Understand the collaboration networks and their dynamics
  • Discover new trends and emerging topics

Please note that a three months access to the full patent database is also included.

Table of Contents

Generalities

  • Brief outline of the technology
  • Brief outline of the market - 2009
  • Brief outline of the pipeline - 2010
  • Patent query

Evolution and location of patent filings

  • Evolution of patent filings (1988-2008)
  • Map and evolution of priority filings
  • Map of extensions
  • Industrial & institutional filings over time
  • Evolution of the number of applicants

Analysis of patent applicants

  • Main applicants on the entire period (1988-2008)
  • Part of the portfolio hold by the first 10 applicants
  • Breakdown of filings of the main industrial/institutional applicants over time
  • Main applicants in the last 4 years (2005-2008)
  • Main co-filings between applicants

Analysis of inventors

  • List of the main inventors
  • Main research teams
  • Emerging inventors

Topics of patent filings

  • Breakdown of the portfolio (for each breakdown is presented the evolution of filings and the positioning of institutional applicants, industrial applicants and inventors)
  • 1. Type of monoclonal antibodies
  • 2. Targets of monoclonal antibodies
    • 2.1. Growth factor receptors
    • 2.2. Molecules involved in cell adhesion
    • 2.3. Other targets
  • 3. Type of digestive system cancers targeted by mAbs

Focus on ROCHE

  • Organization chart
  • Distribution and evolution of patent filings by subsidiaries
  • Filing policy
  • Topics of patent applications
  • Comments

Citation & Extension Analysis

  • List of the most cited patents and patent applications
  • Positioning of patent applications portfolio via citation analysis
  • Most extended patents
  • Coverage rate classification

Conclusion

Appendices

  • mAbs clinical trials by company
  • Applicants/Affiliates

For a deeper analysis ...

... 3 months full access to the patent database :

  • Interactive graphs and tables
  • Access to the patent texts

... we can provide you the patent list corresponding to:

  • A specific applicant portfolio
  • Patents filed a precise year
  • Patents filed in a specific country
  • Patents concerning a specific category
Back to Top